The interplay between the PR and cSrc in breast cancer leads to the activation of signaling pathways involved in proliferation (ERK-MAPKs) (19), migration, and invasion (focal adhesion kinase (Fak)—focal adhesion complexes) (Figure 1) [17,18]. Here, PTK2 is linked to breast carcinoma.